ClearStar revenues continue to grow in 'period of sustained delivery'
Medical screening technology provider ClearStar's chairman Barney Quinn told investors at the group's annual general meeting on Tuesday that 2018 had been a "period of sustained delivery" for the firm.
ClearStar continued to grow its sales, achieve positive underlying earnings and meet its operational targets during the year, driven, in particular, by enhancing its salesforce, increasing brand recognition and securing key integrations with leading applicant tracking systems.
The AIM-listed firm's chairman said the momentum had continued into 2019, with the onboarding of previously-won customers, as well as additional contracts that ClearStar had been awarded since establishing its new sales team towards the end of last year.
Revenue over the first five months of 2019 increased by 14% year-on-year - including achieving the group's highest ever monthly revenue in May 2019.
Quinn said: "As a result, we are on track to achieve strong growth for full year 2019, in line with market expectations.
"We remain committed to growing our business and delivering value for our shareholders, who we thank for their ongoing support. The board remains excited for our future prospects and I look forward to reporting on our progress."
As of 0810 BST, ClearStar shares had slumped 5% to 57p.